Literature DB >> 11689995

Prenatal intervention: ethical considerations for life-threatening and non-life-threatening anomalies.

A W Flake1.   

Abstract

Ethical issues in maternal-fetal surgery require special consideration because of the often-conflicting interests of the mother and fetus. Over the past 2 decades an ethical framework for fetal therapy and maternal-fetal surgery has been developed. This framework continues to evolve as new procedures are developed and new controversies arise. The most recent ethical challenge has been the application of maternal-fetal surgery to nonlethal fetal anomalies, specifically, repair of fetal myelomeningocele. Such procedures require early evaluation by randomized clinical trials to avoid premature dissemination of unproven therapy. These trials currently are being initiated, and the ethical framework for proceeding requires careful consideration. This review will summarize the current ethical issues and controversies in maternal-fetal surgery in the context of these new developments. Copyright 2001 by W.B. Saunders Company

Entities:  

Mesh:

Year:  2001        PMID: 11689995     DOI: 10.1053/spsu.2001.26844

Source DB:  PubMed          Journal:  Semin Pediatr Surg        ISSN: 1055-8586            Impact factor:   2.754


  4 in total

1.  Fetal surgery.

Authors:  Diana Farmer
Journal:  BMJ       Date:  2003-03-01

Review 2.  Surgery in the human fetus: the future.

Authors:  Alan W Flake
Journal:  J Physiol       Date:  2002-08-16       Impact factor: 5.182

3.  Physician views regarding the benefits and burdens of prenatal surgery for myelomeningocele.

Authors:  R M Antiel; C A Collura; A W Flake; M P Johnson; N E Rintoul; J D Lantos; F A Curlin; J C Tilburt; S D Brown; C Feudtner
Journal:  J Perinatol       Date:  2017-06-15       Impact factor: 2.521

4.  A New Ethical Framework for Assessing the Unique Challenges of Fetal Therapy Trials.

Authors:  Saskia Hendriks; Christine Grady; David Wasserman; David Wendler; Diana W Bianchi; Benjamin E Berkman
Journal:  Am J Bioeth       Date:  2021-01-16       Impact factor: 11.229

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.